BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17119783)

  • 1. Laryngeal dystonia: case report and treatment with botulinum toxin.
    Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP
    Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
    Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
    Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
    Blitzer A; Brin MF; Stewart CF
    Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscle.
    Maronian NC; Waugh PF; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):349-55. PubMed ID: 15174760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Singer's dystonia: first report of a variant of spasmodic dysphonia.
    Chitkara A; Meyer T; Keidar A; Blitzer A
    Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):89-92. PubMed ID: 16514788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botox treatment in adductor spasmodic dysphonia: a meta-analysis.
    Boutsen F; Cannito MP; Taylor M; Bender B
    J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
    Inagi K; Rodriquez AA; Ford CN; Heisey DM
    Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.
    Cannito MP; Kahane JC; Chorna L
    Clin Interv Aging; 2008; 3(1):131-51. PubMed ID: 18488884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
    Simpson CB; Lee CT; Hatcher JL; Michalek J
    Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia.
    Lundy DS; Lu FL; Casiano RR; Xue JW
    J Voice; 1998 Dec; 12(4):460-6. PubMed ID: 9988033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved vocal quality and decreased vocal effort after botulinum toxin treatment for laryngeal dystonia.
    Leung JS; Rosenbaum A; Holmberg J; Villarroel P; Napolitano C; Badía PI; Lagos-Villaseca A
    Auris Nasus Larynx; 2024 Feb; 51(1):106-112. PubMed ID: 37365040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
    Blitzer A
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Botulinum toxin efficacy in the treatment of patients with spasmodic dysphonia].
    Svetel M; Vasić M; Tomić G; Stanković P; Stojanović M; Dragasević N; Dergenc R; Vukasinović M; Pekmezović T; Petrović I; Kostić V
    Vojnosanit Pregl; 2007 Oct; 64(10):671-5. PubMed ID: 18041568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
    van Esch BF; Wegner I; Stegeman I; Grolman W
    Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
    Bielamowicz S; Ludlow CL
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurectomy and Myomectomy for Treatment of Spasmodic Dysphonia.
    Ryan W; Alnouri G; Sataloff RT
    J Voice; 2024 Jan; 38(1):239-242. PubMed ID: 35738960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spasmodic Dysphonia.
    Lin J; Sadoughi B
    Adv Otorhinolaryngol; 2020; 85():133-143. PubMed ID: 33166970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.